Abstract
We review the available methods of creating genetically engineered kidneys. These include transgenic technology to introduce novel genes or delete existing genes and methods of gene transfer into the post-natal or adult kidney. The use of such technology has provided insights into renal development and growth and created new animal models of human diseases. Although some of these techniques are of potential use for introducing therapeutically useful gene products into the diseased kidney, many problems remain to be solved before this aim is attained.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Lewin B (1990) Genes IV. Oxford University Press, Oxford
Lee K-F, Li E, Huber J, Londis SC, Sharpe AH, Chao MV, Javenisch R (1992) Targeted mutation of the gene encoding the low affinity NGF Receptor p75 leads to deficits in the peripheral sensory nervous system. Cell 69: 733–749
MacKay K, Striker LJ, Pinkert CA, Brinster RL, Striker GE (1987) Glomerulosclerosis and renal cysts in mice transgenic for the early region of SV40. Kidney Int 32: 827–837
Trudel M, D'Agati V, Costantini F (1991)c-myc as an inducer of polycystic kidney disease in transgenic mice. Kidney Int 39: 665–671
Mullins JJ, Peters J, Gonten D (1990) Fulminant hypertension in transgenic rats harbouring the mouseRen-2 gene. Nature 344: 541–544
Doi T, Striker LJ, Quaiffe C, Conti FG, Palmiter R, Behringer R, Brinster R, Stiker GE (1988) Progressive glomerulosclerosis develops in transgenic mice chronically expressing growth hormone and growth hormone releasing factor but not insulin-like growth factor I. Am J Pathol 131: 398–403
Bard JBL, Woolf AS (1992) Nephrogenesis and the development of renal disease. Nephrol Dial Transplant 7: 563–572
Kress C, Vogels R, DeGraaff V, et al (1990)Hox-2.3 upstream sequences mediatelacZ expression in intermediate mesoderm derivations of transgenic mice. Development 109: 775–786
Sariola H, Saarma M, Sainio K, et al (1991) Dependence of kidney morphogenesis on the expression of nerve growth factor receptor. Science 254: 571–573
Woolf AS, Frischauf A-M, Shaw DG, McCartney SA, Clarkson P (1992) Autosomal dominant polycystic kidney disease. Lancet 339: 1146–1149
Woolf AS, Bosch RJ, Fine LG (1993) Gene transfer into the mammalian kidney: microtransplantation of retrovirus-transduced metanephric tissue. Exp Nephrol 1: 41–48
Bosch RJ, Woolf AS, Fine LG (1993) Gene transfer into the mammalian kidney: direct retrovirus transduction of regenerating tubular epithelial cells. Exp Nephrol 1: 49–54
Herzlinger D, Koseki C, Mikawa T, Al-Awqati Q (1992) Metanephric mesenchyme contains multipotent stem cells whose fate is restricted after induction. Development 114: 565–572
Woolf AS, Palmer SJ, Snow ML, Fine LG (1990) Creation of a functioning chimeric mammalian kidney. Kidney Int 38: 991–997
Scharfmann R, Axelrod JH, Verma IM (1991) Long-term in vivo expression of retrovirus mediated gene transfer in mouse fibroblast implants. Proc Natl Acad Sci USA 88: 4626–4630
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Woolf, A.S., Fine, L.G. Genetically engineered kidneys. Pediatr Nephrol 7, 605–608 (1993). https://doi.org/10.1007/BF00852565
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00852565